The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | 24,500 | 58,000 | -10,200 | -24,000 |
| Loss on sale of real estate, net | 5,500 | 29,300 | 11,100 | 54,300 |
| Depreciation and amortization | 32,200 | 31,800 | 32,600 | 68,600 |
| Above/below market and straight-line rent amortization | -2,100 | 600 | 100 | -300 |
| Uncollectible lease income | 100 | 500 | 1,100 | 700 |
| Accretion of discount on loans receivable | -1,400 | - | 400 | 1,200 |
| Provision for credit losses | 0 | 100 | 900 | 3,100 |
| Benefit from deferred income taxes | -13,300 | 32,000 | -19,100 | -5,000 |
| Amortization of deferred loan costs | 3,100 | 0 | 4,400 | 5,700 |
| Amortization of discount and accretion of premium on issuance of senior notes and mortgage debt | 100 | -500 | -2,300 | 6,000 |
| Unrealized net (gain) loss on derivatives | 7,000 | 400 | -1,700 | -8,300 |
| Loss on early extinguishment of debt | - | -2,300 | - | - |
| Income from unconsolidated investments | 58,500 | 97,100 | 34,500 | 11,200 |
| Operating distributions from unconsolidated investments | 16,300 | 17,800 | 18,600 | 31,200 |
| Accretion of discount on loans | - | 1,900 | - | - |
| Deferred compensation | 1,600 | 3,300 | 6,000 | 1,100 |
| Share-based compensation | 4,600 | 6,400 | 6,500 | 12,800 |
| Accounts receivable | 4,100 | 400 | 100 | 4,000 |
| Other assets | 3,000 | -500 | 5,600 | -1,700 |
| Accounts payable, accrued expenses and other liabilities | -76,700 | 3,600 | 3,800 | -49,100 |
| Net cash used in operating activities | -87,900 | 28,900 | -7,600 | -9,900 |
| Proceeds from collection of loans receivable | 21,600 | 28,000 | 7,900 | 32,900 |
| Issuance and acquisition of loans receivable, net of discounts | 14,400 | 14,700 | 13,600 | 26,000 |
| Net proceeds from sale of consolidated real estate | 103,400 | 111,000 | 30,800 | 423,900 |
| Deposit for unconsolidated investment | - | 6,400 | - | - |
| Purchases of real estate | 38,300 | 73,600 | 0 | 25,700 |
| Capital expenditures to real estate | 9,500 | 35,800 | 10,400 | 20,400 |
| Proceeds from settlement of derivative contracts | - | 0 | - | - |
| Payments for business acquired, net of cash acquired | 8,000 | 29,400 | - | - |
| Premiums paid on derivative contracts | 1,000 | 4,100 | 5,900 | 2,100 |
| Distributions from unconsolidated investments | 52,100 | 59,100 | 141,200 | 167,300 |
| Contributions to unconsolidated investments | 24,700 | 100,000 | 20,400 | 87,800 |
| Contributions from noncontrolling interests | - | 0 | 300 | 0 |
| Net cash provided by (used in) investing activities | 81,200 | -65,900 | 129,600 | 462,100 |
| Borrowings under line of credit | 195,000 | 321,000 | 0 | 170,000 |
| Repayment of line of credit | 109,300 | 138,500 | 0 | 178,700 |
| Borrowings under mortgage debt | 57,100 | 222,700 | 5,200 | 3,600 |
| Repayment of mortgage debt | 89,300 | 154,500 | 10,800 | 304,000 |
| Repayment of kwe notes | - | 352,000 | - | - |
| Payment of loan fees | - | 4,300 | - | - |
| Issuance of common stock, net of issuance costs | - | 0 | 0 | 0 |
| Payment of deferred loan costs | 1,200 | - | 0 | 300 |
| Repurchase and retirement of common stock | 11,800 | 0 | 0 | 9,200 |
| Preferred stock issuance, net of issuance costs | - | 0 | - | - |
| Common dividends paid | 16,700 | 16,500 | 16,600 | 34,900 |
| Preferred dividends paid | 10,900 | 10,900 | 10,800 | 21,800 |
| Loan receivable proceeds received from equity partners | -2,100 | 800 | -14,900 | 15,600 |
| Distributions to noncontrolling interests | 1,100 | 14,900 | 1,200 | 4,700 |
| Net cash provided by financing activities | 9,400 | -146,800 | -48,800 | -364,400 |
| Effect of currency exchange rate changes on cash and cash equivalents | -2,600 | -14,300 | 300 | 3,800 |
| Net change in cash and cash equivalents | 100 | -198,100 | 73,500 | 91,600 |
| Cash and cash equivalents, beginning of period | 184,500 | 382,600 | 217,500 | - |
| Cash and cash equivalents, end of period | 184,600 | 184,500 | 382,600 | - |